Companies: 10,795·Total market cap: $144.5T
Teladoc Health, Inc.

Teladoc Health, Inc.

TDOCNYSEHealthcare● Active
$7.07
+$0.02(+0.21%)
Market Cap$1.3B
P/E Ratio
52W High$9.77
52W Low$4.4

Teladoc Health, Inc. (TDOC) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

tdoc · stock forecast · 42 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 42 Wall Street analysts in the past 3 months

SellBuy

Hold

42 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
14
Hold
28
Sell
0
Strong Sell
0
Total: 42 · Buy rate: 33.3%

12-Month Price Target

High

$11.00

Consensus

$7.58

+7.3% upside

Low

$6.00

Median: $7 · Last Close: $7.07

The Teladoc Health, Inc. (TDOC) analyst consensus is Hold, based on ratings from 42 Wall Street analysts over the past 3 months. The average 12-month TDOC price target is $7.58, representing +7.3% upside from the current price of $7.07.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $8 (7.3%)

Consensus Target

$7.58

7.3% upside

High Target

$11

55.7%

Low Target

$6

-15.1%

Current Price

$7.07

as of today

Based on analyst price targets, the TDOC stock price prediction for the next 12 months ranges from $6 to $11. The consensus TDOC price forecast of $7.58 implies 7.3% upside from the current price of $7.07.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$7.272.86%

1-day model range: $7.21–$7.32. Peak: $7.32 (+2.86%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$4-50.0%
2028$3-63.7%
2029$2-69.2%
2030$2-71.8%
2031-73.1%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

64%7%29%
9Buy
1Neutral
4Sell
RSI (14)61.4Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · TDOC · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$7.21SELL
MA 10$7.23SELL
MA 20$6.91BUY
MA 50$6.25BUY
MA 100$5.80BUY
MA 200$6.80BUY
Current $TDOC · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$7.17SELL
EMA 10$7.14SELL
EMA 20$6.95BUY
EMA 50$6.48BUY
EMA 100$6.34BUY
EMA 200$6.74BUY
Current $TDOC · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Citigroup2026-05-05
Maintains
NeutralNeutral
Evercore ISI Group2026-04-08
Maintains
In LineIn Line
Barclays2026-03-26
Maintains
Equal WeightEqual Weight
JP Morgan2026-03-13
Maintains
NeutralNeutral
Deutsche Bank2026-03-10
Upgrade ↑
HoldBuy
Citigroup2026-03-03
Maintains
NeutralNeutral
Oppenheimer2026-03-03
Maintains
OutperformOutperform
TD Cowen2026-02-26
Maintains
HoldHold
BMO Capital2026-02-26
Maintains
Market PerformMarket Perform
Piper Sandler2026-02-26
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on Teladoc Health, Inc. (TDOC) stock. Of the recent 340 rating actions, 10 were upgrades and 27 were downgrades. 42 analysts currently cover TDOC.

Analyst Recommendation Trends

Buy ratings00
Hold ratings11
Sell ratings00

TDOC analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$2.5B

↓ 2.8% YoY

Revenue Next Year

$2.5B

↑ 1.3% YoY

EPS This Year

$-0.92

EPS Next Year

$-0.66

↓ 27.4% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast TDOC EPS of $-0.92 for the current fiscal year, based on estimates from 11 analysts. The TDOC revenue forecast is $2.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The TDOC stock forecast is supported by two independent data sources: analyst consensus ratings from 42 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus TDOC price target is $7.58 (+7.3% upside), with an analyst consensus of Hold.

The TDOC short-term stock prediction for tomorrow is $7.27 (+2.86%). The TDOC stock price prediction for 2027 estimates an average of $4. The TDOC stock prediction for 2030 projects a range of $2–$2.

Teladoc Health, Inc. trades on NYSE under the ticker TDOC. The TDOC stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 33% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

TDOC forecast · 8 questions

According to 42 Wall Street analysts, the average 12-month TDOC price target is $7.58, with a high forecast of $11.00 and a low of $6.00. The median price target is shown in the chart above when available. This implies +7.3% potential upside from the current price of $7.07.

TDOC price targetWhat is TDOC price targetTDOC analyst price targetTDOC 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.